The researchers will use their new funding to strengthen a vaccine they’ve made from a DNA fragment taken from the HIV genome. The fragment encodes something that is highly prized in HIV/AIDS vaccine research. Called the MPER, it’s a region of the HIV envelope that retains mutations at a very low level compared to the rest of the virus’s genome, which continually mutates.’